Filter
92
Filtered Results: 92
Text search:
pharma
company
Featured
Recommendations
4
New Publications
25
Language
Document type
No document type
38
Studies & Reports
27
Guidelines
13
Manuals
4
Strategic & Response Plan
4
Fact sheets
4
Situation Updates
1
Resource Platforms
1
Countries / Regions
Global
6
India
5
Ethiopia
4
Kenya
4
Nigeria
3
Uganda
3
Philippines
3
South Africa
3
Sierra Leone
2
Senegal
2
Ghana
2
Tanzania
2
Ukraine
2
Nepal
1
Germany
1
Bangladesh
1
Malawi
1
Sudan
1
Authors & Publishers
Publication Years
Category
Countries
28
Clinical Guidelines
10
Women & Child Health
8
Pharmacy & Technologies
8
Public Health
6
Toolboxes
Pharmacy
17
AMR
8
COVID-19
8
HIV
7
NCDs
6
Mental Health
5
Global Health Education
4
NTDs
3
TB
2
Health Financing Toolbox
2
Disability
1
Rapid Response
1
Specific Hazards
1
Caregiver
1
Planetary Health
1
Key Features:
• Module Users: Disaster Management Trainers
• Training Targets: State Government and District
officials / Disaster Management Authorities / Disaster
Management Planners and Responders
• Training Duration: 5 working days (one week)
• Trainers Input: Multi-disciplinary
...
The overall goal of the programme, to reduce the malaria morbidity and mortality by 75% (using 2012 as baseline) by the year 2020, continued to be pursued in 2014. The following areas were identified as some of the priorities for the year: Malaria Case Management under which we have Malaria in Pregn...
Objective: To review research on associations of trauma type with PTSD in the WHO World Mental Health (WMH) surveys, a series of epidemiological surveys that obtained representative data on trauma-specific PTSD.
20 February 2013
Update on 2004 Background Paper (Written by Saloni Tanna)
Priority Medicines for Europe and the World "A Public Health Approach to Innovation"
This paper focuses on the Sustainable Development Goals related to poverty, economic growth, inequality, health, food production and the environment. It presents concrete examples of the underlying and complex aspects of antibiotic resistance and its impacts across different Sustainable Development ...
Depress Anxiety. 2018 March ; 35(3): 195–208. doi:10.1002/da.22711.
В настоящем отчете (это уже четвертое его издание) анализируются препятствия и факторы, затрудняющие доступ к препаратам для лечения лекарственно-устойчивого туб...
SADJ August 2016, Vol 71 no 7 p314 - p318
Clinical Review
Global UNIDO Project: Strengthening the local production of essential medicines in least developed and developing countries
Screening programmes for tuberculosis (TB) among immigrants rarely consider the heterogeneity of
risk related to migrants’ country of origin. We assess the performance of a large screening programme in asylum seekers by analysing (i) the difference in yield and numbers needed to screen (NNS) by c...
To support its R&D activities on Chagas disease, DNDi launched the Chagas Clinical Research Platform (CCRP). The platform brings together partners, experts, and stakeholders to provide support for evaluation and development of new treatments for Chagas disease. The patient-centred platform aims to f...
Development finance institutions owned by European governments and the World Bank Group are spending hundreds of millions of dollars on expensive for-profit hospitals in the Global South that block patients from getting care, or bankrupt them, with some even imprisoning patients who cannot afford th...
ABSTRACT
More than 500 million people worldwide live with cardiovascular disease (CVD). Health systems today face fundamental challenges in delivering optimal care due to ageing populations, healthcare workforce constraints, financing, availability and affordability of CVD medicine, and service del...
The World Heart Federation (WHF) Roadmap series covers a large range of cardiovascular conditions. These Roadmaps identify potential roadblocks and their solutions to improve the prevention, detection and management of cardiovascular diseases and provide a generic global framework available for loca...
Cardiovascular diseases (CVDs) have collectively remained the leading causes of death worldwide and substantially contribute to loss of health and excess health system costs. The Global Burden of Diseases, Injuries, and Risk Factors (GBD) Study has tracked trends in death and disability since 1990 a...
